Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
2(22%)
Results Posted
40%(2 trials)
Terminated
1(11%)

Phase Distribution

Ph phase_2
4
44%
Ph not_applicable
5
56%

Phase Distribution

0

Early Stage

4

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
4(44.4%)
N/ANon-phased studies
5(55.6%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

2

trials recruiting

Total Trials

9

all time

Status Distribution
Active(2)
Completed(5)
Terminated(1)
Other(1)

Detailed Status

Completed5
Active, not recruiting1
Recruiting1
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
2
Success Rate
83.3%
Most Advanced
Phase 2

Trials by Phase

Phase 24 (44.4%)
N/A5 (55.6%)

Trials by Status

active_not_recruiting111%
completed556%
recruiting111%
terminated111%
unknown111%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
OTHER
Total Trials
9